Counterpoint Mutual Funds’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-42,537
Closed -$675K – 491
2026
Q2
$675K Sell
42,537
-333,201
-89% -$5.16M 0.07% 123
2026
Q1
$5.08M Buy
375,738
+146,742
+64% +$2.05M 0.76% 8
2025
Q4
$2.85M Buy
+228,996
New +$2.47M 0.21% 55

Other funds holding VTRS

Counterpoint Mutual Funds's VTRS Position: Q3 2026 in Review

Counterpoint Mutual Funds sold out of Viatris (VTRS) in Q3 2026, closing a stake of 42,537 shares — an estimated $675K sold.

Counterpoint Mutual Funds first reported a position in VTRS in Q4 2025 and held it in 3 quarters. The position peaked at $5.08M in Q1 2026. 864 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Counterpoint Mutual Funds reported no remaining Viatris position as of Q3 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 42,537 Viatris shares in Q3 2026, an estimated $675K.
  • Counterpoint Mutual Funds first reported a position in Viatris in Q4 2025 and held it in 3 quarters.
  • Counterpoint Mutual Funds's Viatris position peaked at $5.08M in Q1 2026.
  • 864 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.